Fibrinolytic

Fibrinolytic

Fibrinolytic (Fibrinotytic) - this term is used to describe a group of medicinal substances that can break down the protein fibrin, which is the basis of blood clots; Therefore, these medicinal substances are used to dissolve blood clots (thrombi) that form in the blood vessels. These drugs include: streptokinase, alteplase, antistreplase and urokinase. Possible side effects: bleeding at the injection site, headache and back pain, bruising of the skin and allergic reactions.

Fibrinolytic drugs (fibrinolytics) are a group of drugs that can break down fibrin, the basis of blood clots. This allows them to be used to resolve blood clots that can form in blood vessels during various diseases.

Fibrinolytic drugs include streptokinase, alteplase, antistreptolysin and urokinase.

Streptokinase and alteplase are proteolytic enzymes that break down fibrin and promote its dissolution. Antistreplase is an antitoxin that neutralizes the action of streptokinase and altepase. Urokinase is an endogenous enzyme that is also involved in the breakdown of fibrin.

The use of fibrinolytic drugs can be accompanied by various side effects, such as bleeding at the injection site, headache, back pain and allergic reactions. Therefore, before using these drugs, you should consult your doctor and follow his recommendations.

Fibrinolysis is the process of natural dissolution of inflammatory products and blood clots inside a bleeding wound. Fibrinoid necrosis is a pathological repair process after cuts or soft tissue trauma in which blood clotting products form the basis of a thick substance surrounded by a liquid substance.